The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Activation of the Complement System by Synthetic DNA Complexes: A Potential Barrier for Intravenous Gene Delivery
Abstract
We have examined the complement-activating properties of synthetic cationic molecules and their complexes with DNA. Commonly used gene delivery vehicles include complexes of DNA with polylysine of various chain lengths, transferrin-polylysine, a fifth-generation poly(amidoamine) (PAMAM) dendrimer, poly(ethyleneimine), and several cationic lipids (DOTAP, DC-Chol/DOPE, DOGS/DOPE, and DOTMA/DOPE). These agents activate the complement system to varying extents. Strong complement activation is seen with long-chain polylysines, the dendrimer, poly(ethyleneimine), and DOGS (half-maximal at about 3 μM amine content in the assay used). Compared to these compounds, the other cationic lipids (in liposome formulations) are weak activators of the complement system (half-maximal ≈ 50–100 μM positive charge in assay). Complement activation by polylysine is strongly dependent on the chain length. Short-chain oligolysines are comparable to cationic lipids in their activation of complement. Incubation of these compounds with DNA to form complexes reduces complement activation in virtually all cases. The degree of complement activation by DNA complexes is strongly dependent on the ratio of polycation and DNA (expressed as the charge ratio) for polylysine, dendrimer, poly(ethyleneimine), and DOGS. To a lesser degree, charge ratio also influences complement activation by monovalent cationic lipid–DNA complexes. For polylysine–DNA complexes, complement activation can be considerably reduced by modifying the surface of preformed DNA complexes with polyethyleneglycol (half-maximal ≈ 20 μM amine content). The data suggests that, by appropriate formulation of DNA complexes, complement activation can be minimized or even avoided. These findings should facilitate the search for DNA complex formulations appropriate for reproducible intravenous gene delivery. Successful gene delivery upon intravenous administration of DNA complexes has been reported in several cases. However, there is considerable variability and poor reproducibility with such systems. The variability makes it difficult to understand which of the multitude of factors that impact this mode of gene delivery limits the reproducibility. Limiting parameters may include the stability of DNA complexes in blood and their interaction with blood components. Such interactions may limit the half-life and targetability of DNA complexes. The components of the complement system are likely candidates to interact with (opsonize) intravenously administered DNA complexes. To find out whether DNA complexes activate the complement system, we have examined a number of synthetic cationic molecules frequently used in gene delivery and their complexes with DNA for their complement-activating properties. The results indicate that complement activation is a potential limiting factor for gene delivery by synthetic DNA complexes. Furthermore, appropriate formulation of DNA complexes can minimize or avoid complement activation and possibly other interactions with blood components.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
A New Class of Polymers: Starburst-Dendritic Macromolecules
Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., & Smith, P. (1985) · Polymer Journal · doi:10.1295/polymj.17.117 · Cited by 3,904
Polyamidoamine cascade polymers mediate efficient transfection of cells in culture
Haensler, J., & Szoka, F. C. (1993) · Bioconjugate Chemistry · doi:10.1021/bc00023a012 · Cited by 1,207
Self-citationSterically stabilized liposomes
Woodle, M. C., & Lasic, D. D. (1992) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(92)90038-c · Cited by 954
Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA.
Behr, J. P., Demeneix, B., Loeffler, J. P., & Perez-Mutul, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.6982 · Cited by 719
Liposomes for the sustained drug release in vivo
Blume, G., & Cevc, G. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90440-y · Cited by 698
Transferrin-polycation conjugates as carriers for DNA uptake into cells.
Wagner, E., Zenke, M., Cotten, M., Beug, H., & Birnstiel, M. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.9.3410 · Cited by 655
Self-citationReceptor-mediated gene delivery and expression in vivo.
Wu, G. Y., & Wu, C. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68081-0 · Cited by 635
The Classical Complement Pathway: Activation and Regulation of the First Complement Component
Cooper, N. R. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60340-5 · Cited by 510
Adenovirus–mediated in vivo gene transfer and expression in normal rat liver
Jaffe, H. A., Danel, C., Longenecker, G., Metzger, M., Setoguchi, Y., Rosenfeld, M. A., Gant, T. W., Thorgeirsson, S. S., Stratford-Perricaudet, L. D., Perricaudet, M., et al. (1992) · Nature Genetics · doi:10.1038/ng0892-372 · Cited by 449
Adenovirus enhancement of transferrin-polylysine-mediated gene delivery.
Curiel, D. T., Agarwal, S., Wagner, E., & Cotten, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8850 · Cited by 423
Self-citationGene Transfer with Synthetic Cationic Amphiphiles: Prospects for Gene Therapy
Behr, J.-P. (1994) · Bioconjugate Chemistry · doi:10.1021/bc00029a002 · Cited by 368
Chonn, A., Cullis, P. R., & Devine, D. V. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.12.4234 · Cited by 367
Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats
Wu, G. Y., Wilson, J. M., Shalaby, F., Grossman, M., Shafritz, D. A., & Wu, C. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98689-8 · Cited by 340
Perales, J. C., Ferkol, T., Beegen, H., Ratnoff, O. D., & Hanson, R. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4086 · Cited by 301
Kozarsky, K. F., McKinley, D. R., Austin, L. L., Raper, S. E., Stratford-Perricaudet, L. D., & Wilson, J. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36886-2 · Cited by 293
Wu, C. H., Wilson, J. M., & Wu, G. Y. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71447-6 · Cited by 287
Wagner, E., Curiel, D., & Cotten, M. (1994) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(94)90008-6 · Cited by 275
Self-citationZenke, M., Steinlein, P., Wagner, E., Cotten, M., Beug, H., & Birnstiel, M. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3655 · Cited by 272
Self-citationSystemic gene therapy: biodistribution and long-term expression of a transgene in mice.
Thierry, A. R., Lunardi-Iskandar, Y., Bryant, J. L., Rabinovich, P., Gallo, R. C., & Mahan, L. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9742 · Cited by 240
Cationic Liposome-mediated Intravenous Gene Delivery
Liu, Y., Liggitt, D., Zhong, W., Tu, G., Gaensler, K., & Debs, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24864 · Cited by 231
Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum
Klerx, J. P. A. M., Beukelman, C. J., Van Dijk, H., & Willers, J. M. N. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90425-8 · Cited by 191
A Novel Series of Amphiphilic Imidazolinium Compounds for in Vitro and in Vivo Gene Delivery
Solodin, I., Brown, C. S., Bruno, M. S., Chow, C.-Y., Jang, E.-H., Debs, R. J., & Heath, T. D. (1995) · Biochemistry · doi:10.1021/bi00041a033 · Cited by 189
Cotten, M. L., Baker, A. T., Saltik, M., et al. (1994) · PubMed · Cited by 164
Interaction of positively-charged liposomes with blood: implications for their application in vivo
Senior, J. H., Trimble, K. R., & Maskiewicz, R. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90160-a · Cited by 157
Physicochemical and Pharmacokinetic Characteristics of Plasmici DNA/ Cationic Liposome Complexes
Mahato, R. I., Kawabata, K., Nomura, T., et al. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600841102 · Cited by 155
Ferkol, T. W., Perales, J. C., Eckman, E. A., Kaetzel, C. S., Hanson, R. W., & Davis, P. B. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117690 · Cited by 151
Wagner, E., Cotten, M. L., Mechtler, K., Kirlappos, H., & Birnstiel, M. L. (1991) · Bioconjugate Chemistry · doi:10.1021/bc00010a006 · Cited by 148
Self-citationGene delivery and expression mediated by an integrin-binding peptide.
Hart, S. L., Harbottle, R. P., Cooper, R., Miller, A. D., Williamson, R. E., & Coutelle, C. C. (1995) · PubMed · Cited by 142
Complement Activation by Interaction of Polyanions and Polycations
Claus, D. R., Siegel, J. N., Petras, K., Skor, D., Osmand, A. P., & Gewurz, H. (1977) · The Journal of Immunology · doi:10.4049/jimmunol.118.1.83 · Cited by 135
Tomlinson, S. (1993) · Current Opinion in Immunology · doi:10.1016/0952-7915(93)90085-7 · Cited by 122
Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor.
Ferkol, T. W., Kaetzel, C. S., & Davis, P. B. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116845 · Cited by 112
DNA binds and activates complement via residues 14-26 of the human C1q A chain.
Jiang, H., Cooper, B. J., Robey, F. A., & Gewurz, H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74082-4 · Cited by 109
Canonico, A. E., Plitman, J. D., Conary, J. T., Meyrick, B. O., & Brigham, K. L. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.77.1.415 · Cited by 103
Targeted Gene Delivery with a Low Molecular Weight Glycopeptide Carrier
Wadhwa, M. S., Knoell, D. L., Young, A. P., & Rice, K. G. (1995) · Bioconjugate Chemistry · doi:10.1021/bc00033a008 · Cited by 102
Wicks, I. P., Howell, M. L., Hancock, T., Kohsaka, H., Olee, T., & Carson, D. A. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.3-317 · Cited by 86
The location of binding sites on C1q for DNA.
Uwatoko, S., & Mannik, M. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.9.3484 · Cited by 34
Complement Activation by Polylysine-DNA Complexes
Plank, C., Mechtler, K., Wagner, E., & Szoka, F. C. (1996) · Springer eBooks · doi:10.1007/978-1-4615-6405-8_13 · Cited by 5
Self-citation
Cited by
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Malik, N., Wiwattanapatapee, R., Klopsch, R., Lorenz, K., Frey, H., Weener, J. W., Meijer, E. W., Paulus, W., & Duncan, R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00246-1 · Cited by 1,227
Dendron-Mediated Self-Assembly, Disassembly, and Self-Organization of Complex Systems
Rosen, B. M., Wilson, C. J., Wilson, D. A., Peterca, M., Imam, M. R., & Percec, V. (2009) · Chemical Reviews · doi:10.1021/cr900157q · Cited by 1,204
Poly(ethylenimine) and its role in gene delivery
Godbey, W. T., Wu, K. K., & Mikos, A. G. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00090-5 · Cited by 1,199
Ogris, M., Brunner, S., Schüller, S., Kircheis, R., & Wagner, E. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300900 · Cited by 1,178
Self-citation
Metadata
- Authors
- Plank, C., Mechtler, K., Szoka, F. C., & Wagner, E.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1996-08
- Volume
- 7
- Issue
- 12
- Pages
- 1437-1446
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2003904826
- Cited by
- 583
- References
- 38
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.